Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40258-021-00679-9.pdf
Reference53 articles.
1. Modig N. What do economic scholars consider powerful economic knowledge of importance for people in their private and public lives? Implications for teaching and learning economics in social studies. Stud High Educ [Internet]. 2020. https://doi.org/10.1080/03075079.2020.1716319.
2. Culyer AJ. Cost, context, and decisions in health economics and health technology assessment. Int J Technol Assess Health Care [Internet]. 2018;34(5):434–41. https://www.cambridge.org/core/product/identifier/S0266462318000612/type/journal_article. Accessed 18 Jun 2019.
3. Palmer S, Raftery J. Opportunity cost. BMJ [Internet]. 1999;318(7197):1551. https://www.bmj.com/content/318/7197/1551. Accessed 9 Dec 2020.
4. Ferraro PJ, Taylor LO. Do economists recognize an opportunity cost when they see one? A dismal performance from the dismal science. Contrib Econ Anal Policy [Internet]. 2005;4(1):1–12. Available from: https://www.degruyter.com/view/journals/bejeap/4/1/article-p1.xml. Accessed 9 Dec 2020.
5. Potter J, Sanders S. Do economists recognize an opportunity cost when they see one? A dismal performance or an arbitrary concept? South Econ J Internet. 2012;79(2):248–56. https://doi.org/10.4284/0038-4038-2011.218.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Resource allocation in public sector programmes: does the value of a life differ between governmental departments?;Cost Effectiveness and Resource Allocation;2023-12-15
2. How Uncertainty Matters Under Risk Neutrality;Value in Health;2023-08
3. Economic evaluation of self-help group interventions for health in LMICs: a scoping review;Health Policy and Planning;2023-07-27
4. Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease;PharmacoEconomics - Open;2023-06-12
5. What are economic costs and when should they be used in health economic studies?;Cost Effectiveness and Resource Allocation;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3